IR-Med, Inc. financial data

Symbol
IRME on OTC
Location
C/O Aboudi Legal Group Pllc, 745 5 Th Ave, Suite 500, New York, NY
State of incorporation
NV
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Apr 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 312 %
Debt-to-equity -15.1K % -32637%
Return On Equity 50.6K %
Return On Assets -338 % -33.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 72M shares +2.97%
Common Stock, Shares, Outstanding 71M shares +1.54%
Entity Public Float 24.4M USD -39.3%
Common Stock, Value, Issued 70K USD +1.45%
Weighted Average Number of Shares Outstanding, Basic 70.8M shares +2.79%
Weighted Average Number of Shares Outstanding, Diluted 70.5M shares +1.54%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 710K USD -65.6%
General and Administrative Expense 1.01M USD -50.1%
Operating Income (Loss) -1.94M USD +60.5%
Nonoperating Income (Expense) -6K USD -400%
Net Income (Loss) Attributable to Parent -1.9M USD +61.3%
Earnings Per Share, Basic -0.03 USD/shares +57.1%
Earnings Per Share, Diluted -0.03 USD/shares +57.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 129K USD -83.2%
Accounts Receivable, after Allowance for Credit Loss, Current 76K USD -6.17%
Assets, Current 205K USD -75.8%
Property, Plant and Equipment, Net 35K USD -37.5%
Operating Lease, Right-of-Use Asset 40K USD -60%
Assets 251K USD -74.9%
Accounts Payable, Current 114K USD +78.1%
Employee-related Liabilities, Current 28K USD -71.4%
Accrued Liabilities, Current 188K USD +17.5%
Liabilities, Current 545K USD +15.2%
Long-term Debt and Lease Obligation 13K USD -83.3%
Operating Lease, Liability, Noncurrent 2K USD
Liabilities 545K USD -14%
Retained Earnings (Accumulated Deficit) -16.7M USD -12.8%
Stockholders' Equity Attributable to Parent -294K USD -181%
Liabilities and Equity 251K USD -74.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -358K USD +60.2%
Common Stock, Shares Authorized 600M shares 0%
Common Stock, Shares, Issued 71M shares +1.54%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -359K USD +60.1%
Deferred Tax Assets, Valuation Allowance 2.34M USD +11.7%
Deferred Tax Assets, Gross 2.34M USD +10.7%
Operating Lease, Liability 39K USD -65.8%
Depreciation 9K USD +125%
Lessee, Operating Lease, Liability, to be Paid 50K USD -58.3%
Property, Plant and Equipment, Gross 93K USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11K USD +83.3%
Deferred Tax Assets, Operating Loss Carryforwards 2.18M USD +30%
Additional Paid in Capital 16.4M USD +8.19%